• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭症状群:一项系统综述。

Cluster of symptoms in kidney failure: A systematic review.

作者信息

Gomariz-Ruiz Jaime, Pérez-Cruzado David, Gutiérrez-Sánchez Daniel

机构信息

Faculty of Health Sciences, University of Málaga, 29071, Málaga, Spain.

Department of Physiotherapy, Faculty of Health Sciences, University of Málaga, 29071, Málaga, Spain.

出版信息

Heliyon. 2024 Dec 28;11(1):e41556. doi: 10.1016/j.heliyon.2024.e41556. eCollection 2025 Jan 15.

DOI:10.1016/j.heliyon.2024.e41556
PMID:39845015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11750532/
Abstract

BACKGROUND

Chronic kidney disease is a global problem characterized by a progressive decrease in kidney function with associated symptoms. A better understanding of these symptoms could lead to the development of personalized strategies.

OBJECTIVE

This systematic review aims to describe the clusters of symptoms in kidney failure and categorize them according to their time of onset and how disabling they are for patients.

DESIGN

A systematic review was carried out.

METHODS

This systematic review was conducted according to the PRISMA declaration standards. The search engines used were initially limited to WOS, Embase, and PubMed, and they were employed between November 2022 and January 2023. In addition, the bibliographic search was supplemented with databases of the grey literature, such as OpenGrey, in May 2023. The following inclusion criteria were established: cross-sectional studies, studies on adult populations, and studies dealing with clusters of symptoms associated with kidney failure. Before an article was definitively selected, the checklist of the STROBE initiative, with a maximum of 22 points, was applied, assessing the quality of cross-sectional articles. Articles were selected independently and blinded by two researchers, and a third researcher was involved in case of disagreement.

RESULTS

After carrying out the bibliographic search, we found that eight articles, out of the 46 articles that were evaluated, fully met the inclusion criteria. Two tables were made, which include important information, such as the participants' profiles or the way the authors extracted a cluster of symptoms.

LIMITATIONS

The main area for improvement is that it was not possible to perform a meta-analysis due to the methodology used in the articles analysed. Constraining the selection of articles to those written in Spanish or English could be a limitation as not all articles dealing with symptom clusters in kidney failure were considered.

CONCLUSIONS

Common symptoms in clusters of symptoms in kidney failure were nausea or vomiting (gastrointestinal problems), fatigue or muscle weakness (neuromuscular symptoms/problems), low interest in sex or difficulty feeling sexually excited (sexual symptoms), dry skin or skin itching (skin problems), lack of appetite, feeling squeezed, feeling weak or dizzy and difficulty breathing (uraemic), fatigue or muscle weakness (energy/vitality), and chest pain (cardiac-related problems). Providing treatment based on clusters of symptoms would benefit the patient more than providing treatment based on isolated symptoms. The identification of symptom clusters in kidney failure has clinical relevance, and this research could facilitate the development of adequate intervention strategies, simplifying the treatment offered to patients and even reducing the side effects of treatments.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a77/11750532/9e8626d393da/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a77/11750532/9e8626d393da/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a77/11750532/9e8626d393da/gr1.jpg
摘要

背景

慢性肾脏病是一个全球性问题,其特征是肾功能逐渐下降并伴有相关症状。更好地了解这些症状有助于制定个性化策略。

目的

本系统评价旨在描述肾衰竭患者的症状群,并根据其发作时间以及对患者的致残程度进行分类。

设计

进行了一项系统评价。

方法

本系统评价按照PRISMA声明标准进行。最初使用的搜索引擎仅限于Web of Science(WOS)、Embase和PubMed,检索时间为2022年11月至2023年1月。此外,在2023年5月,通过OpenGrey等灰色文献数据库对文献检索进行了补充。制定了以下纳入标准:横断面研究、针对成年人群的研究以及涉及与肾衰竭相关症状群的研究。在最终选定一篇文章之前,应用了STROBE倡议的清单(满分22分)来评估横断面文章的质量。由两名研究人员独立且盲法筛选文章,如有分歧则由第三名研究人员参与。

结果

在进行文献检索后,我们发现,在评估的46篇文章中,有8篇完全符合纳入标准。制作了两个表格,其中包括重要信息,如参与者的概况或作者提取症状群的方式。

局限性

主要的改进方向是,由于所分析文章使用的方法,无法进行荟萃分析。将文章选择限制在西班牙语或英语撰写的文章可能是一个局限性,因为并非所有涉及肾衰竭症状群的文章都被考虑在内。

结论

肾衰竭症状群中的常见症状包括恶心或呕吐(胃肠道问题)、疲劳或肌肉无力(神经肌肉症状/问题)、性欲低下或性兴奋困难(性症状)、皮肤干燥或皮肤瘙痒(皮肤问题)、食欲不振、有压迫感、虚弱或头晕以及呼吸困难(尿毒症)、疲劳或肌肉无力(能量/活力)和胸痛(心脏相关问题)。基于症状群提供治疗比基于孤立症状提供治疗对患者更有益。识别肾衰竭中的症状群具有临床意义,这项研究有助于制定适当的干预策略,简化为患者提供的治疗,甚至减少治疗的副作用。

相似文献

1
Cluster of symptoms in kidney failure: A systematic review.肾衰竭症状群:一项系统综述。
Heliyon. 2024 Dec 28;11(1):e41556. doi: 10.1016/j.heliyon.2024.e41556. eCollection 2025 Jan 15.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.从婴儿和新生儿获取器官或组织用于移植、研究或商业目的的伦理问题:生物伦理学范围审查方案
Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024.
5
Public sector reforms and their impact on the level of corruption: A systematic review.公共部门改革及其对腐败程度的影响:一项系统综述。
Campbell Syst Rev. 2021 May 24;17(2):e1173. doi: 10.1002/cl2.1173. eCollection 2021 Jun.
6
Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.安抚奶嘴使用与母乳喂养、婴儿猝死综合征、感染及牙列不齐之间的关联。
JBI Libr Syst Rev. 2005;3(6):1-33. doi: 10.11124/01938924-200503060-00001.
7
Symptom clusters in patients on dialysis and their association with quality-of-life outcomes.透析患者的症状群及其与生活质量结果的关联。
J Ren Care. 2014 Mar;40(1):23-33. doi: 10.1111/jorc.12051. Epub 2014 Jan 18.
8
Evidence-informed practice versus evidence-based practice educational interventions for improving knowledge, attitudes, understanding, and behavior toward the application of evidence into practice: A comprehensive systematic review of UG student.基于证据的实践与循证实践教育干预对提高本科学生将证据应用于实践的知识、态度、理解和行为的影响:一项全面的系统综述
Campbell Syst Rev. 2022 Apr 16;18(2):e1233. doi: 10.1002/cl2.1233. eCollection 2022 Jun.
9
Telephone interventions for symptom management in adults with cancer.针对成年癌症患者症状管理的电话干预措施。
Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2.
10
Is immediate imaging important in managing low back pain?在处理下腰痛时,立即进行影像学检查重要吗?
J Athl Train. 2011 Jan-Feb;46(1):99-102. doi: 10.4085/1062-6050-46.1.99.

本文引用的文献

1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
Clinical Determinants of Frailty in End-stage Renal Disease.终末期肾病患者虚弱的临床决定因素。
J Coll Physicians Surg Pak. 2022 Nov;32(11):1506-1508. doi: 10.29271/jcpsp.2022.11.1506.
3
Symptom cluster: management and advanced practices in oncology nursing.症状群:肿瘤护理管理与高级实践。
Rev Esc Enferm USP. 2022 Jun 27;56(spe):e20210452. doi: 10.1590/1980-220X-REEUSP-2021-0452en. eCollection 2022.
4
Dialysis symptom index burden and symptom clusters in a prospective cohort of dialysis patients.透析患者前瞻性队列中的透析症状指数负担和症状群。
J Nephrol. 2022 Jun;35(5):1427-1436. doi: 10.1007/s40620-022-01313-0. Epub 2022 Apr 16.
5
Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy.针对慢性肾脏病和透析治疗患者瘙痒相关不良症状群的新方法。
Curr Opin Nephrol Hypertens. 2022 Jan 1;31(1):63-71. doi: 10.1097/MNH.0000000000000752.
6
Mucocutaneous manifestations of patients with chronic kidney disease under hemodialysis: A cross-sectional study of 49 patients.血液透析慢性肾脏病患者的黏膜皮肤表现:49 例患者的横断面研究。
Dermatol Ther. 2021 Jul;34(4):e15015. doi: 10.1111/dth.15015. Epub 2021 Jun 18.
7
Suffering and Symptoms At the End of Life in ICU Patients Undergoing Renal Replacement Therapy.终末期 ICU 行肾脏替代治疗患者的痛苦和症状。
Am J Hosp Palliat Care. 2021 Dec;38(12):1509-1515. doi: 10.1177/10499091211005707. Epub 2021 Apr 8.
8
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
9
Assessment of health-related quality of life and its determinants in the pre-dialysis patients with chronic kidney disease.评估慢性肾脏病透析前患者的健康相关生活质量及其决定因素。
Int Urol Nephrol. 2022 Jan;54(1):165-172. doi: 10.1007/s11255-021-02846-2. Epub 2021 Mar 26.
10
Alterations in symptoms and health-related quality of life as kidney function deteriorates: A cross-sectional study.肾功能恶化时症状和健康相关生活质量的变化:一项横断面研究。
J Clin Nurs. 2021 Jun;30(11-12):1787-1796. doi: 10.1111/jocn.15738. Epub 2021 Mar 11.